ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 1 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | – | 36 | +3500.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q3 2018 | $873,000 | -13.4% | 226,844 | -24.0% | 0.00% | – |
Q2 2018 | $1,008,000 | +1801.9% | 298,644 | +1094.6% | 0.00% | – |
Q1 2018 | $53,000 | -98.0% | 25,000 | -97.1% | 0.00% | – |
Q1 2016 | $2,671,000 | -29.9% | 867,314 | -12.4% | 0.00% | -100.0% |
Q4 2015 | $3,812,000 | +25.2% | 990,014 | -0.8% | 0.00% | – |
Q3 2015 | $3,045,000 | -31.0% | 998,314 | -4.0% | 0.00% | -100.0% |
Q2 2015 | $4,410,000 | -33.8% | 1,040,114 | -39.7% | 0.00% | 0.0% |
Q1 2015 | $6,659,000 | +1.8% | 1,725,253 | +77.6% | 0.00% | 0.0% |
Q4 2014 | $6,539,000 | +79.6% | 971,601 | +46.5% | 0.00% | – |
Q3 2014 | $3,641,000 | -46.4% | 663,239 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $6,798,000 | -19.9% | 663,239 | -6.2% | 0.00% | 0.0% |
Q1 2014 | $8,492,000 | +6.2% | 707,039 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $7,997,000 | -8.5% | 707,039 | -12.8% | 0.00% | 0.0% |
Q3 2013 | $8,736,000 | +6.1% | 811,139 | -8.7% | 0.00% | 0.0% |
Q2 2013 | $8,232,000 | – | 888,039 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |